Moore KN, Lorusso D, Oaknin A, Oza A, et al. Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary. Gynecol Oncol 2024;191:249-258.
PMID: 39461270